Abstract
The S100 proteins family is known to affect neuroinflammation and astrocyte activation, which have been suggested to be contributors to the pathogenesis of schizophrenia. We conducted a systematic meta-analysis of S100 genes differential expression in postmortem samples of patients with schizophrenia vs. healthy controls, following the commonly used Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. Twelve microarray datasets met the inclusion criteria (overall 511 samples, 253 schizophrenia and 258 controls were analyzed). Nine out of 21 genes were significantly up-regulated or with tendency for up-regulation. A per-sample fold change analysis indicated that the S100 genes’ up-regulation was concentrated in a subgroup of the patients. None of the genes have been found to be down-regulated. ANXA3, which encodes Annexin 3 protein and was associated with neuroinflammation, was up-regulated and positively correlated with the S100 genes’ expression pattern. In addition, astrocytes and endothelial cell markers were significantly correlated with S100A8 expression. S100 correlation with ANXA3 and endothelial cell markers suggests that the up-regulation we detected reflects increased inflammation. However, it might also reflect astrocytes abundance or activation. The fact that S100 proteins were shown to be up-regulated in blood samples and other body fluids of patients with schizophrenia suggests a potential role as biomarkers, which might help disease subtyping, and the development of etiological treatments for immune dysregulation in schizophrenia.
Similar content being viewed by others
Data Availability
The data in this article were derived from the GEO (http://www.ncbi.nlm.nih.gov/geo/) and the Stanley Medical Research Institute (SMRI) Array Collection (http://www.stanleyresearch.org/brain-research/array-collection/), as described in the methods section and in the Supplementary information file.
References
Ahmed, A. O., Strauss, G. P., Buchanan, R. W., Kirkpatrick, B., & Carpenter, W. T. (2018). Schizophrenia heterogeneity revisited: Clinical, cognitive, and psychosocial correlates of statistically-derived negative symptoms subgroups. Journal of Psychiatric Research, 97, 8–15. https://doi.org/10.1016/j.jpsychires.2017.11.004
Barnes, M. R., Huxley-Jones, J., Maycox, P. R., Lennon, M., Thornber, A., Kelly, F., Bates, S., Taylor, A., Reid, J., Jones, N., Schroeder, J., Scorer, C. A., Davies, C., Hagan, J. J., Kew, J. N. C., Angelinetta, C., Akbar, T., Hirsch, S., Mortimer, A. M., … de Belleroche, J. (2011). Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophrenia. Journal of Neuroscience Research, 89(8), 1218–1227. https://doi.org/10.1002/jnr.22647
Boerrigter, D., Weickert, T. W., Lenroot, R., O’donnell, M., Galletly, C., Liu, D., Burgess, M., Cadiz, R., Jacomb, I., Catts, V. S., Fillman, S. G., & Weickert, C. S. (2017). Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder. Journal of Neuroinflammation. https://doi.org/10.1186/s12974-017-0962-y
Bowden, N. A., Scott, R. J., & Tooney, P. A. (2008). Altered gene expression in the superior temporal gyrus in schizophrenia. BMC Genomics. https://doi.org/10.1186/1471-2164-9-199
Bowen, E. F. W., Burgess, J. L., Granger, R., Kleinman, J. E., & Rhodes, C. H. (2019). DLPFC transcriptome defines two molecular subtypes of schizophrenia. Translational Psychiatry. https://doi.org/10.1038/s41398-019-0472-z
Cai, H. Q., Catts, V. S., Webster, M. J., Galletly, C., Liu, D., O’donnell, M., Weickert, T. W., & Weickert, C. S. (2020). Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation. Molecular Psychiatry, 25, 761–775. https://doi.org/10.1038/s41380-018-0235-x
Chen, C., Meng, Q., Xia, Y., Ding, C., Wang, L., Dai, R., Cheng, L., Gunaratne, P., Gibbs, R. A., Min, S., Coarfa, C., Reid, J. G., Zhang, C., Jiao, C., Jiang, Y., Giase, G., Thomas, A., Fitzgerald, D., Brunetti, T., … Liu, C. (2018). The transcription factor POU3F2 regulates a gene coexpression network in brain tissue from patients with psychiatric disorders. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aat8178
Dean, B., Gray, L., & Scarr, E. (2006). Regionally specific changes in levels of cortical S100β in bipolar 1 disorder but not schizophrenia. Australian and New Zealand Journal of Psychiatry, 40, 217–224.
Dietz, A. G., Goldman, S. A., & Nedergaard, M. (2020). Glial cells in schizophrenia: a unified hypothesis. The Lancet Psychiatry, 7(3), 272–281. https://doi.org/10.1016/S2215-0366(19)30302-5
Donato, R. (2001). S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. The International Journal of Biochemistry & Cell Biology, 33, 637–668.
Fleiss, J. L. (1993). The random effects model. Statistical Methods in Medical Research, 2, 121–145.
Fromer, M., Roussos, P., & Sieberts, S. K. (2016). Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nature Neuroscience. https://doi.org/10.1038/nn.4399
Gandal, M. J., Haney, J. R., Parikshak, N. N., Leppa, V., Ramaswami, G., Hartl, C., Schork, A. J., Appadurai, V., Buil, A., Werge, T. M., Liu, C., White, K. P., Horvath, S., & Geschwind, D. H. (2018). Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science, 359, 693–697.
Gardiner, E. J., Cairns, M. J., Liu, B., Beveridge, N. J., Carr, V., Kelly, B., Scott, R. J., & Tooney, P. A. (2013). Gene expression analysis reveals schizophrenia-associated dysregulation of immune pathways in peripheral blood mononuclear cells. Journal of Psychiatric Research, 47(4), 425–437. https://doi.org/10.1016/j.jpsychires.2012.11.007
Gerke, V., & Moss, S. E. (2002). Annexins: From structure to function. Physiological Reviews. https://doi.org/10.1152/physrev.00030.2001.-Annexins
Gogtay, N., Vyas, N. S., Testa, R., Wood, S. J., & Pantelis, C. (2011). Age of onset of schizophrenia: Perspectives from structural neuroimaging studies. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbr030
Golubinskaya, V., Puttonen, H., Fyhr, I. M., Rydbeck, H., Hellström, A., Jacobsson, B., Nilsson, H., Mallard, C., & Sävman, K. (2020). Expression of S100A alarmins in cord blood monocytes is highly associated with chorioamnionitis and fetal inflammation in preterm infants. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2020.01194
Guo, B., Jiang, T., Wu, F., Ni, H., Ye, J., Wu, X., Ni, C., Jiang, M., Ye, L., Li, Z., Zheng, X., Li, S., Yang, Q., Wang, Z., Huang, X., & Zhao, C. (2022). LncRNA RP5-998N21.4 promotes immune defense through upregulation of IFIT2 and IFIT3 in schizophrenia. Schizophrenia. https://doi.org/10.1038/s41537-021-00195-8
Hedges, L. (1981). Distribution theory for glass’s estimator of effect size and related estimators. Source: Journal of Educational Statistics, 6(2).
Hertzberg, L., Maggio, N., Muler, I., Yitzhaky, A., Majer, M., Haroutunian, V., Zuk, O., Katsel, P., Domany, E., & Weiser, M. (2021a). Comprehensive gene expression analysis detects global reduction of proteasome subunits in schizophrenia. Schizophrenia Bulletin, 47(3), 785–795. https://doi.org/10.1093/schbul/sbaa160
Hertzberg, L., Zohar, A. H., & Yitzhaky, A. (2021b). Gene expression meta-analysis of cerebellum samples supports the fkbp5 gene-environment interaction model for schizophrenia. Life. https://doi.org/10.3390/LIFE11030190
Hoffman, G. E., Bendl, J., Voloudakis, G., Montgomery, K. S., Sloofman, L., Wang, Y.-C., Shah, H. R., Hauberg, M. E., Johnson, J. S., Girdhar, K., Song, L., Fullard, J. F., Kramer, R., Hahn, C.-G., Gur, R., Marenco, S., Lipska, B. K., Lewis, D. A., Haroutunian, V., … Roussos, P. (2019). CommonMind Consortium provides transcriptomic and epigenomic data for Schizophrenia and Bipolar Disorder. Scientific Data. https://doi.org/10.1038/s41597-019-0183-6
Iavarone, F., Melis, M., Platania, G., Cabras, T., Manconi, B., Petruzzelli, R., Cordaro, M., Siracusano, A., Faa, G., Messana, I., Zanasi, M., & Castagnola, M. (2014). Characterization of salivary proteins of schizophrenic and bipolar disorder patients by top-down proteomics. Journal of Proteomics, 103, 15–22. https://doi.org/10.1016/j.jprot.2014.03.020
Iwamoto, K., Kakiuchi, C., Bundo, M., Ikeda, K., & Kato, T. (2004). Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Molecular Psychiatry, 9, 406–416. https://doi.org/10.1038/sj.mp.4001437
Joaquim, H. P. G., Costa, A. C., Serpa, M. H., Talib, L. L., & Gattaz, W. F. (2020). Reduced Annexin A3 in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 270, 489–494. https://doi.org/10.1007/s00406-019-01048-3
Junker, H., Suofu, Y., Venz, S., Sascau, M., Herndon, J. G., Kessler, C., Walther, R., & Popa-Wagner, A. (2007). Proteomic identification of an upregulated isoform of Annexin A3 in the rat brain following reversible cerebral ischemia. Glia. https://doi.org/10.1002/glia.20581
Jurga, A. M., Paleczna, M., Kadluczka, J., & Kuter, K. Z. (2021). Beyond the GFAP-astrocyte protein markers in the brain. Biomolecules. https://doi.org/10.3390/biom11091361
Katsel, P., Byne, W., Roussos, P., Tan, W., Siever, L., & Haroutunian, V. (2011). Astrocyte and glutamate markers in the superficial, deep, and white matter layers of the anterior cingulate gyrus in schizophrenia. Neuropsychopharmacology, 36, 1171–1177. https://doi.org/10.1038/npp.2010.252
Kontkanen, O., Törö, P., Lakso, M., Wong, G., & Castrén, E. (2002). Antipsychotic drug treatment induces differential gene expression in the rat cortex. Journal of Neurochemistry, 83, 1043–1053.
Kulohoma, B. W., Marriage, F., Vasieva, O., Mankhambo, L., Nguyen, K., Molyneux, M. E., Molyneux, E. M., Day, P. J. R., & Carrol, E. D. (2017). Peripheral blood RNA gene expression in children with pneumococcal meningitis: A prospective case-control study. BMJ Paediatrics Open. https://doi.org/10.1136/BMJPO-2017-000092
Kurian, S. M., Le-Niculescu, H., Patel, S. D., Bertram, D., Davis, J., Dike, C., Yehyawi, N., Lysaker, P., Dustin, J., Caligiuri, M., Lohr, J., Lahiri, D. K., Nurnberger, J. I., Faraone, S., Geyer, M. A., Tsuang, M. T., Schork, N. J., Salomon, D. R., & Niculescu, A. B. (2011). Identification of blood biomarkers for psychosis using convergent functional genomics. Molecular Psychiatry, 16(1), 37–58. https://doi.org/10.1038/mp.2009.117
Lanz, T. A., Reinhart, V., Sheehan, M. J., Rizzo, S. J. S., Bove, S. E., James, L. C., Volfson, D., Lewis, D. A., & Kleiman, R. J. (2019a). Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: A comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder. Translational Psychiatry. https://doi.org/10.1038/s41398-019-0492-8
le Cabec, V., & Maridonneau-Parini, I. (1994). Annexin 3 is associated with cytoplasmic granules in neutrophils and monocytes and translocates to the plasma membrane in activated cells. Biochemical Journal, 303(2), 481–487. https://doi.org/10.1042/BJ3030481
Leza, J. C., Bueno, B., Bioque, M., Arango, C., Parellada, M., Do, K., O’Donnell, P., & Bernardo, M. (2015). Inflammation in schizophrenia: A question of balance. Neuroscience & Biobehavioral Reviews, 55, 612–626. https://doi.org/10.1016/J.NEUBIOREV.2015.05.014
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009). Guidelines and guidance The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Medicine. https://doi.org/10.1371/journal.pmed.1000100
Maycox, P. R., Kelly, F., Taylor, A., Bates, S., Reid, J., Logendra, R., Barnes, M. R., Larminie, C., Jones, N., Lennon, M., Davies, C., Hagan, J. J., Angelinetta, C., Akbar, T., Hirsch, S., Mortimer, A. M., Barnes, T., & de Belleroche, J. (2009). Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function. Molecular Psychiatry, 14, 1083–1094. https://doi.org/10.1038/mp.2009.18
Mcgrath, J., Saha, S., Chant, D., & Welham, J. (2008). Schizophrenia: A concise overview of incidence, prevalence, and mortality. Iranian Journal of Psychiatry and Behavioral Sciences. https://doi.org/10.1093/epirev/mxn001
Merikangas, A. K., Shelly, M., Knighton, A., Kotler, N., Tanenbaum, N., & Almasy, L. (2022). What genes are differentially expressed in individuals with schizophrenia? A systematic review. Molecular Psychiatry, 27(3), 1373–1383. https://doi.org/10.1038/S41380-021-01420-7
Mirnics, K., Levitt, P., & Lewis, D. A. (2006). Critical appraisal of DNA microarrays in psychiatric genomics. Biological Psychiatry, 60(2), 163–176. https://doi.org/10.1016/j.biopsych.2006.02.003
Murai, N. (2020). Functional analysis of CX3CR1 in human induced pluripotent stem (iPS) cell-derived microglia-like cells. Maisam Mitalipova 1 | Rudolf Jaenisch, 52, 3. https://doi.org/10.1111/ejn.14879
Nishiyama, H., Knöpfel, T., & Endo, S. (2002). Glial Protein S100B Modulates Long-Term Neuronal Synaptic Plasticity on JSTOR. National Academy of Sciences. https://www.jstor.org/stable/3058247?seq=1#metadata_info_tab_contents
Ohtsuki, S., Sato, S., Yamaguchi, H., Kamoi, M., Asashima, T., & Terasaki, T. (2007). Exogenous expression of claudin-5 induces barrier properties in cultured rat brain capillary endothelial cells. Journal of Cellular Physiology, 210, 81–86. https://doi.org/10.1002/jcp.20823
Oved, K., Morag, A., Pasmanik-Chor, M., Rehavi, M., Shomron, N., & Gurwitz, D. (2013). Genome-wide expression profiling of human lymphoblastoid cell lines implicates integrin beta-3 in the mode of action of antidepressants. Translational Psychiatry. https://doi.org/10.1038/tp.2013.86
Paz, R. D., Andreasen, N. C., & Daoud, S. Z. (2006). Increased expression of activity dependent genes in cerebellar glutamatergic neurons of patients with schizophrenia. American Journal of Psychiatry, 163, 1829–1831.
Pérez-Santiago, J., Diez-Alarcia, R., Callado, L. F., Zhang, J. X., Chana, G., White, C. H., Glatt, S. J., Tsuang, M. T., Everall, I. P., Meana, J. J., & Woelk, C. H. (2012). A combined analysis of microarray gene expression studies of the human prefrontal cortex identifies genes implicated in schizophrenia. Journal of Psychiatric Research, 46(11), 1464–1474. https://doi.org/10.1016/j.jpsychires.2012.08.005
Pietersen, C. Y., Mauney, S. A., Kim, S. S., Lim, M. P., Rooney, R. J., Goldstein, J. M., Petryshen, T. L., Seidman, L. J., Shenton, M. E., McCarley, R. W., Sonntag, K.-C., & Woo, T.-U.W. (2014a). Molecular profiles of pyramidal neurons in the superior temporal cortex in schizophrenia. Journal of Neurogenetics, 28, 1–2. https://doi.org/10.3109/01677063.2014.882918
Pietersen, C. Y., Mauney, S. A., Kim, S. S., Passeri, E., Lim, M. P., Rooney, R. J., Goldstein, J. M., Petreyshen, T. L., Seidman, L. J., Shenton, M. E., Mccarley, R. W., Sonntag, K.-C., & Woo, T.-U.W. (2014b). Molecular profiles of parvalbumin-immunoreactive neurons in the superior temporal cortex in schizophrenia. Journal of Neurogenetics, 28, 70–85. https://doi.org/10.3109/01677063.2013.878339
Pong, S., Lizano, P., & Karmacharya, R. (2020). Derivation, expansion, cryopreservation and characterization of brain microvascular endothelial cells from human induced pluripotent stem cells corresponding author date published. Journal of Visualized Experiments, 165, 61629. https://doi.org/10.3791/61629
Pope, P. T., & Webster, J. T. (1972). The use of an F-statistic in stepwise regression procedures. Technometrics, 14(2), 327.
Ramaker, R. C., Bowling, K. M., Lasseigne, B. N., Hagenauer, M. H., Hardigan, A. A., Davis, N. S., Gertz, J., Cartagena, P. M., Walsh, D. M., Vawter, M. P., Schatzberg, A. F., Barchas, J. D., Watson, S. J., Bunney, B. G., Akil, H., Bunney, W. E., Li, J. Z., Cooper, S. J., & Myers, R. M. (2017). Post-mortem molecular profiling of three psychiatric disorders. Genome Medicine. https://doi.org/10.1186/s13073-017-0458-5
Réus, G. Z., Fries, G. R., Stertz, L., Badawy, M., Passos, I. C., Barichello, T., Kapczinski, F., & Quevedo, J. (2015). The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders. Neuroscience, 300, 141–154. https://doi.org/10.1016/J.NEUROSCIENCE.2015.05.018
Roder, J. K., Roder, J. C., & Gerlai, R. (1996). Conspecific exploration in the T-maze: Abnormalities in S100β transgenic mice. Physiology and Behavior, 60(1), 31–36. https://doi.org/10.1016/0031-9384(95)02247-3
Roussos, P., Mitchell, A. C., Voloudakis, G., Fullard, J. F., Pothula, V. M., Tsang, J., Stahl, E. A., Georgakopoulos, A., Ruderfer, D. M., Charney, A., Okada, Y., Siminovitch, K. A., Worthington, J., Padyukov, L., Klareskog, L., Gregersen, P. K., Plenge, R. M., Raychaudhuri, S., Fromer, M., … Sklar, P. (2014). A Role for Noncoding Variation in Schizophrenia. Cell Reports, 9(4), 1417–1429. https://doi.org/10.1016/j.celrep.2014.10.015
Sárvári, A. K., Veréb, Z., Uray, I. P., Fésüs, L., & Balajthy, Z. (2014). Atypical antipsychotics induce both proinflammatory and adipogenic gene expression in human adipocytes in vitro. Biochemical and Biophysical Research Communications, 450(4), 1383–1389. https://doi.org/10.1016/J.BBRC.2014.07.005
Schümberg, K., Polyakova, M., Steiner, J., & Schroeter, M. L. (2016). Serum s100b is related to illness duration and clinical symptoms in schizophrenia—A meta-regression analysis. Frontiers in Cellular Neuroscience. https://doi.org/10.3389/fncel.2016.00046
Schwarzer, G. (2007). meta: An R package for meta-analysis. Psychometrics in R Journal of Statistical Software, 20(1).
Smoller, J. W., Andreassen, O. A., Edenberg, H. J., Faraone, S. V., Glatt, J., & Kendler, K. S. (2019). Psychiatric genetics and the structure of psychopathology. Molecular Psychiatry, 24, 409–420. https://doi.org/10.1038/s41380-017-0010-4
Steiner, J., Bernstein, H.-G., Bielau, H., Farkas, N., Winter, J., Dobrowolny, H., Brisch, R., Gos, T., Mawrin, C., Myint, A. M., & Bogerts, B. (2008). S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: A morphometric study. Journal of Psychiatric Research. https://doi.org/10.1016/j.jpsychires.2007.10.001
Steiner, J., Bielau, H., & Bernstein, H.-G. (2006). Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones. Journal of Neurology, Neurosurgery and Psychiatry, 77, 1284–1287. https://doi.org/10.1136/jnnp.2006.093427
Steiner, J., Schmitt, A., Schroeter, M. L., Bogerts, B., Falkai, P., & Turck, C. W. (2014). S100B is downregulated in the nuclear proteome of schizophrenia corpus callosum. European Archives of Psychiatry and Clinical Neuroscience. https://doi.org/10.1007/s00406-014-0490-z
Toker, L., Mancarci, B. O., Tripathy, S., & Pavlidis, P. (2018). Transcriptomic evidence for alterations in astrocytes and parvalbumin interneurons in subjects with bipolar disorder and schizophrenia. Biological Psychiatry, 84(11), 787–796. https://doi.org/10.1016/j.biopsych.2018.07.010
Trépanier, M. O., Hopperton, K. E., Mizrahi, R., Mechawar, N., & Bazinet, R. P. (2016). Postmortem evidence of cerebral inflammation in schizophrenia: A systematic review. Molecular Psychiatry, 21, 1009–1026. https://doi.org/10.1038/mp.2016.90
Trubetskoy, V., Pardiñas, A. F., Qi, T., Panagiotaropoulou, G., Awasthi, S., Bigdeli, T. B., Bryois, J., Chen, C.-Y., Dennison, C. A., Hall, L. S., Lam, M., Watanabe, K., Frei, O., Ge, T., Harwood, J. C., Koopmans, F., Magnusson, S., Richards, A. L., Sidorenko, J., … van Os, J. (2022). Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature, 604(7906), 502–508. https://doi.org/10.1038/S41586-022-04434-5
Tsuang, M. T., Nossova, N., Yager, T., Tsuang, M. M., Guo, S. C., Kou, G. S., Glatt, S. J., & Liew, C. C. (2005). Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: A preliminary report. American Journal of Medical Genetics - Neuropsychiatric Genetics, 133B(1), 1–5. https://doi.org/10.1002/ajmg.b.30161
Wu, T., Liang, X., Jiang, Y., Chen, Q., Zhang, H., Zhang, S., Zhang, C., Lv, Y., Xin, J., Jiang, J., Shi, D., Chen, X., Li, J., & Xu, Y. (2020). Comprehensive transcriptome profiling of peripheral blood mononuclear cells from patients with sepsis. International Journal of Medical Sciences, 17(14), 2077. https://doi.org/10.7150/IJMS.46910
Yao, Y., Schröder, J., & Karlsson, H. (2008). Verification of proposed peripheral biomarkers in mononuclear cells of individuals with schizophrenia. Journal of Psychiatric Research, 42(8), 639–643. https://doi.org/10.1016/j.jpsychires.2007.07.011
Zeidán-Chuliá, F., Neves De Oliveira, B.-H., Casanova, M. F., Casanova, E. L., Noda, M., Salmina, A. B., & Verkhratsky, A. (2016). Up-regulation of oligodendrocyte lineage markers in the cerebellum of autistic patients: Evidence from network analysis of gene expression. Molecular Neurobiology. https://doi.org/10.1007/s12035-015-9351-7
Zeng, J., Xue, A., Jiang, L., Lloyd-Jones, L. R., Wu, Y., Wang, H., Zheng, Z., Yengo, L., Kemper, K. E., Goddard, M. E., Wray, N. R., Visscher, P. M., & Yang, J. (2021). Widespread signatures of natural selection across human complex traits and functional genomic categories. Nature Communications. https://doi.org/10.1038/s41467-021-21446-3
Acknowledgements
We thank Professor Eytan Domany for his help with the infrastructure that enabled the performance of this project.
Funding
The meta-analysis was partially funded by Marguerite Stolz Research Fellowship Fund for Junior Faculty in Medicine and Health Professions in Tel-Aviv University. The funders did not have any role in the performance of this meta-analysis.
Author information
Authors and Affiliations
Contributions
LH and AS designed and planned the project. AY performed the computational analysis. AS, AS, VH, PK, and LH interpreted the biological significance of the results. AS wrote the manuscript and LH and AS edited it.
Corresponding author
Ethics declarations
Competing Interests
All Authors declare that there is no conflict of interest.
Ethical Approval
No Institutional Review Board approvals were required for this study, as all findings were derived from published datasets, as stated below under “Availability of data and materials.”
Consent to Participate
No informed consent to participate statements were required for this study, as all findings were derived from datasets, as stated below under “Availability of data and materials.”
Consent for Publication
No informed consent for publication statements were required for this study, as all findings were derived from datasets, as stated below under “Availability of data and materials.”
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Shamir, A., Yitzhaky, A., Segev, A. et al. Up-Regulation of S100 Gene Family in Brain Samples of a Subgroup of Individuals with Schizophrenia: Meta-analysis. Neuromol Med 25, 388–401 (2023). https://doi.org/10.1007/s12017-023-08743-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12017-023-08743-4